Title |
Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry
|
---|---|
Published in |
Clinical Research in Cardiology, December 2014
|
DOI | 10.1007/s00392-014-0804-1 |
Pubmed ID | |
Authors |
Jana Mareike Nührich, Karl-Heinz Kuck, Dietrich Andresen, Daniel Steven, Stefan G. Spitzer, Ellen Hoffmann, Burghard Schumacher, Lars Eckardt, Johannes Brachmann, Thorsten Lewalter, Matthias Hochadel, Jochen Senges, Stephan Willems, Boris A. Hoffmann |
Abstract |
Atrial fibrillation (AF) is the most common cause of ischemic stroke. Recent data suggest that AF patients after successful ablation have the same risk for thromboembolic events (TE) as patients without AF. Despite current guideline recommendations it is still under debate if oral anticoagulation (OAC) can be safely discontinued after ablation. We analyzed follow-up (FU) after ablation of paroxysmal AF (PAF) in a high- (previous stroke; group 1) and a low-risk group (no previous stroke; group 2) based on data from the German Ablation Registry to reveal real-life prescription behavior. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 33% |
United Kingdom | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Slovenia | 1 | 2% |
Unknown | 45 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 13% |
Researcher | 6 | 13% |
Other | 5 | 11% |
Student > Bachelor | 3 | 7% |
Student > Master | 3 | 7% |
Other | 6 | 13% |
Unknown | 17 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 35% |
Computer Science | 3 | 7% |
Agricultural and Biological Sciences | 3 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Other | 2 | 4% |
Unknown | 18 | 39% |